The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...

It was better than Stelara in reaching PASI 90 and IGA 0/1 at that timepoint, and also topped placebo on the more stringent PASI 100 and IGA 0 measures, which represent completely clear skin.

Results from previous phase 3 trials showed riskankizumab outperformed J&J’s Stelara (ustekinumab), an IL-12 and IL-23 blocker, and Humira against the PASI 90 and sPGA (0/1) measures in psoriasis.

The FDA is reportedly proposing that cosmetic products containing talc be tested for the presence of asbestos, a known ...

Blue chip stocks provide strong returns and growing dividends, ideal for stable investment. Top blue chips like Apple and Berkshire Hathaway are leaders in their industries with high market caps ...

BAT2206 is a proposed biosimilar to Jansen’s Stelara ®. Bio-Thera has filed for regulatory approval of BAT2206 with the China National Medical Products Administration (NMPA), the European Medicines ...

Aa Aaaaaaa A Aaa 117.07 +21.01% ...

Approval marks the first generic version of liraglutide injection, referencing Victoza, for improving glycemic control in adults and children aged 10 years and older with type 2 diabetes, alongside ...

051900.KS LG H&H Co., Ltd.

High-Throughput Analysis of Volatile Compounds in Air, Water, and Soil Using SIFT-MS ...

001630.KS Chong Kun Dang Holdings Corp.